[Long-term survival in a patient receiving multidisciplinary therapy for hepatocellular carcinoma with left iliac bone metastasis].
The patient was a 79-year-old man diagnosed with a single 9.3-cm hepatocellular carcinoma (HCC) in the medial segment of the liver, and left iliac bone metastasis. Initially, the patient was treated with a hepatic arterial infusion of low-dose FP (cisplatin/5-fluorouracil) at another hospital. Here, the patient received particle therapy for the left iliac bone metastasis at a total dose of 52.8 Gy in 4 fractions. Subsequently, he underwent medial segmentectomy of the liver to treat the primary HCC. Eleven months later, the first intrahepatic recurrence occurred, and the tumor was treated with percutaneous radiofrequency ablation (RFA). A second intrahepatic recurrence was detected 39 months later, which was also treated with percutaneous RFA. The patient remains well, with no evidence of tumor recurrence.
Dept. of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine.
Shinichi
S
So
Masahiro
M
Kido
Takumi
T
Fukumoto
Atsushi
A
Takebe
Motofumi
M
Tanaka
Hisoka
H
Kinoshita
Kaori
K
Kuramitsu
Daisuke
D
Tsugawa
Kenji
K
Fukushima
Takeshi
T
Urade
Toshihiko
T
Yoshida
Sadaki
S
Asari
Taro
T
Okazaki
Makoto
M
Shinzeki
Ippei
I
Matsumoto
Tetsuo
T
Ajiki
Yonson
Y
Ku
D000005:Abdomen / Q000473:pathology*; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary / Q000628:therapy*; D006528:Carcinoma, Hepatocellular / Q000556:secondary / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000628:therapy*; D008297:Male; D014057:Tomography, X-Ray Computed
D002945:Cisplatin; D005472:Fluorouracil